Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Interim / Quarterly Report 2009

Oct 30, 2008

65022_rns_2008-10-30_dbde52d7-233c-4fb2-86be-dc7832fc4949.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Rule 4.7B

Appendix 4C

Quarterly report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001, 24/10/2005.

Name of entity

GENETIC TECHNOLOGIES LIMITED

ABN 17 009 212 328

Quarter ended (“current quarter”)

30 SEPTEMBER 2008

Consolidated statement of cash flows

Consolidated statement of cash flows
Cash flows related to operating activities
1.1
Receipts from customers
1.2
Payments for
(a) staff costs
(b) advertising and marketing
(c) research and development
(d) leased assets
(e) other working capital
1.3
Dividends received
1.4
Interest and items of a similar nature received
1.5
Interest and other costs of finance paid
1.6
Income taxes paid
1.7
Grant and other income
Net operating cash flows
Current quarter
(September 2008)
$A
Year to date
(three months)
$A
3,303,038
(1,817,691)
(47,664)
(869,000)
-
(1,501,023)
-
186,631
(15,766)
-
-
3,303,038

(1,817,691)
(47,664)
(869,000)
-
(1,501,023)
-
186,631
(15,766)
-
-
(761,475) (761,475)
  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 1

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Consolidated statement of cash flows (cont.)

Consolidated statement of cash flows (cont.)
Current quarter
(September 2008)
$A
Year to date
(three months)
$A
1.8
Net operating cash flows (carried forward)
(761,475) (761,475)
Cash flows related to investing activities
1.9
Payment for the acquisition of:
a)
businesses (item 5)
b)
equity investments
c)
intellectual property
d)
physical non-current assets
e)
other non-current assets
1.10
Proceeds from the disposal of:
a)
businesses (item 5)
b)
equity investments
c)
intellectual property
d)
physical non-current assets
e)
joint venture interest
1.11
Loans to other entities
1.12
Loans repaid by other entities
1.13
Other (provide details if material)
Net investing cash flows
1.14
Total operating and investing cash flows
(153,160)
-
-
(20,289)
-
-
-
-
359,236
100,000
-
-
-
(153,160)
-
-
(20,289)
-
-
-
-
359,236
100,000
-
-
-
**285,787 ** **285,787 **
(475,688) (475,688)
Cash flows related to financing activities
1.15
Proceeds from the issue of shares
1.16
Proceeds from sale of forfeited shares
1.17
Proceeds from borrowings
1.18
Repayment of borrowings from third parties
1.19
Dividends paid
1.20
Repayment of finance lease principal
Net financing cash flows
-
-
-
(346,840)
-
(61,265)
-
-
-
(346,840)
-
(61,265)
(408,105) (408,105)
Net increase / (decrease) in cash held
1.21
Cash at beginning of quarter / year to date
1.22
Exchange rate adjustments
1.23
Cash at end of quarter
(883,793)
13,370,772
81,520
(883,793)
13,370,772
81,520
12,568,499 12,568,499
  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 2

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities

1.24
Aggregate amount of payments to the parties included in item 1.2
1.25
Aggregate amount of loans to the parties included in item 1.11
Current quarter
$A
277,350
-
  • 1.26 Explanation necessary for an understanding of the transactions

The amount included at Item 1.24 includes $104,500 paid in consulting fees, bonuses, commissions, Directors’ fees, superannuation and salaries to Directors and entities associated with Directors during the quarter. The amount also includes rental and outgoings of $133,098 for the Melbourne laboratory premises paid to an entity associated with a Director and fees amounting to $39,752 in relation to advisory services provided by a Company associated with another Director.

Non-cash financing and investing activities

  • 2.1 Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows

On 22 July 2008, the Company acquired 100% of the issued capital of Frozen Puppies Dot Com Pty. Ltd. (“FPDC”), Australia’s foremost provider of canine reproductive services. Under the terms of the Agreement between the Company and FPDC, Genetic Technologies Limited (“GTG”) acquired 100% of the issued share capital of FPDC in return for the issue to the FPDC shareholders of 12,254,902 ordinary shares in GTG and the payment of $153,160 in cash. In other terms of the acquisition, GTG advanced $346,840 in loan funds to FPDC to enable shareholder loans to be repaid and Employment Agreements were executed between the Company and the five principals of FPDC. Voluntary Restriction Agreements were also executed with all former FPDC shareholders. As a result, 80% of the 12,254,902 GTG shares that were issued as part of the acquisition are subject to voluntary escrow and will be released from escrow in four equal tranches after the expiration of 6, 12, 18 and 24 months from the date of issue, respectively.

  • 2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

On 27 August 2008, the Company sold its entire interest in the North Laverton Joint Venture to its partner, Regis Resources Limited (“Regis”), in return for the payment of $100,000 in cash and 500,000 fully paid ordinary shares in Regis. As part of the sale, the Company will also have returned to it a performance bond which had a face value of $68,917 as at 30 June 2008. Further, the Company has been fully indemnified by Regis against any future rehabilitation liabilities which may arise from the exploration activities of the Joint Venture undertaken up until the date of sale. This indemnification will enable the Company, during the financial year ending 30 June 2009, to fully reverse the provision of $94,987 in respect of such liabilities which has been recorded in the Company’s balance sheet as at 30 June 2008.

  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 3

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Financing facilities available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

  • 3.1 Loan facilities

  • 3.2 Credit standby arrangements Hire purchase facility

Amount available
$A
Amount used
$A
- -
2,500,000 488,934

Reconciliation of cash

Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows:

  • 4.1 Cash on hand and at bank

  • 4.2 Term deposits

  • 4.3 Bank overdraft

  • 4.4 Commercial Bills of Exchange

  • Total cash at end of quarter (item 1.23)

Current quarter
(September 2008)
$A
Previous quarter
(June 2008)
$A
4,575,582 5,490,843
7,992,917 7,879,929
- -
- -
12,568,499 13,370,772

Acquisitions and disposals of business entities

  • 5.1 Name of entity

  • 5.2 Place of incorporation or registration

  • 5.3 Consideration for acquisition or disposal (note)

  • 5.4 Total net assets

  • 5.5 Nature of business

tities
Acquisitions
(Item 1.9(a))
Disposals
(Item 1.10(a))
Frozen Puppies
Dot Com Pty. Ltd.
Not applicable
New South Wales
$1,403,160
$106,876
Provision of canine
reproductive services

Note: Total consideration comprises $153,160 in cash and shares in GTG with an agreed value of $1,250,000.

  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 4

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Compliance statement

  • 1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.

  • 2 This statement does give a true and fair view of the matters disclosed.

Sign here: ............................................................ Chief Executive Officer

Date: 31 October 2008

Print name: Michael B. Ohanessian

  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 5

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Notes

  1. The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.

  2. The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.

  3. 6.2 - reconciliation of cash flows arising from operating activities to operating profit or loss

  4. 9.2 - itemised disclosure relating to acquisitions

  5. 9.4 - itemised disclosure relating to disposals

  6. 12.1(a) - policy for classification of cash items

  7. 12.3 - disclosure of restrictions on use of cash

  8. 13.1 - comparative information

  9. Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

  • See chapter 19 for defined terms.

24/10/2005

Appendix 4C Page 6